Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Zuzana Kos,
Elvire Roblin,
Rim S Kim,
Stefan Michiels,
Brandon D Gallas,
Weijie Chen,
Koen K van de Vijver,
Shom Goel,
Sylvia Adams,
Sandra Demaria,
Giuseppe Viale,
Torsten O Nielsen,
Sunil S Badve,
W Fraser Symmans,
Christos Sotiriou,
David L Rimm,
Stephen Hewitt,
Carsten Denkert,
Sibylle Loibl,
Stephen J Luen,
John MS Bartlett,
Peter Savas,
Giancarlo Pruneri,
Deborah A Dillon,
Maggie Chon U Cheang,
Andrew Tutt,
Jacqueline A Hall,
Marleen Kok,
Hugo M Horlings,
Anant Madabhushi,
Jeroen van der Laak,
Francesco Ciompi,
Anne-Vibeke Laenkholm,
Enrique Bellolio,
Tina Gruosso,
Stephen B Fox,
Juan Carlos Araya,
Giuseppe Floris,
Jan Hudeček,
Leonie Voorwerk,
Andrew H Beck,
Jen Kerner,
Denis Larsimont,
Sabine Declercq,
Gert van den Eynden,
Lajos Pusztai,
Anna Ehinger,
Wentao Yang,
Khalid AbdulJabbar,
Yinyin Yuan,
Rajendra Singh,
Crispin Hiley,
Maise al Bakir,
Alexander J Lazar,
Stephen Naber,
Stephan Wienert,
Miluska Castillo,
Giuseppe Curigliano,
Maria-Vittoria Dieci,
Fabrice André,
Charles Swanton,
Jorge Reis-Filho,
Joseph Sparano,
Eva Balslev,
I-Chun Chen,
Elisabeth Ida Specht Stovgaard,
Katherine Pogue-Geile,
Kim RM Blenman,
Frédérique Penault-Llorca,
Stuart Schnitt,
Sunil R Lakhani,
Anne Vincent-Salomon,
Federico Rojo,
Jeremy P Braybrooke,
Matthew G Hanna,
M Teresa Soler-Monsó,
Daniel Bethmann,
Carlos A Castaneda,
Karen Willard-Gallo,
Ashish Sharma,
Huang-Chun Lien,
Susan Fineberg,
Jeppe Thagaard,
Laura Comerma,
Paula Gonzalez-Ericsson,
Edi Brogi,
Sherene Loi,
Joel Saltz,
Frederick Klaushen,
Lee Cooper,
Mohamed Amgad,
David A Moore,
Roberto Salgado,
International Immuno-Oncology Biomarker Working Group
May 12, 2021
Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) and HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible...